Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer. - Chang J; Lucas MC; Leonte LE; Garcia-Montolio M; Singh LB; Findlay AD; Deodhar M; Foot JS; Jarolimek W; Timpson P; Erler JT; Cox TR (Oncotarget, 2017)